AstraZeneca
AZN
AZN
1,060 hedge funds and large institutions have $34.9B invested in AstraZeneca in 2022 Q4 according to their latest regulatory filings, with 171 funds opening new positions, 317 increasing their positions, 356 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more call options, than puts
Call options by funds: $468M | Put options by funds: $466M
0.63% less ownership
Funds ownership: 33.5% → 32.87% (-0.63%)
11% less repeat investments, than reductions
Existing positions increased: 317 | Existing positions reduced: 356
Holders
1,060
Holding in Top 10
19
Calls
$468M
Puts
$466M
Top Buyers
| 1 | +$238M | |
| 2 | +$235M | |
| 3 | +$148M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$140M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$99.2M |
Top Sellers
| 1 | -$426M | |
| 2 | -$280M | |
| 3 | -$235M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$234M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$205M |